期刊文献+

小分子药物抑制SARS病毒的体外实验研究 被引量:1

Eperimental study on screening of small molecular drugs in vitro for inhibiting SARS coronavirus.
在线阅读 下载PDF
导出
摘要 目的 为探索SARS的治疗药物 ,实验观察合成的 13种小分子药物抑制SARS冠状病毒的效果。 方法 采用微孔塑料板病变法及MTT法 ,通过观察细胞病变 (CPE)及OD值测定结果 ,判定药效。 结果  13种小分子药物中 3、4、7和 8号药物在接种SARS病毒后 2 0h内对SARS冠状病毒有抑制作用 ;9号药物在接种病毒后 3 0h内药效显著 ;接种SARS病毒 3 6h后 ,SARS病毒繁殖迅速 ,48h后全部发生细胞病变 ,微孔板病变法与MTT法结果一致。 结论  13种药物中有 5种药物在2 4h内对SARS冠状病毒有一定的抑制作用 ,3 0h后所有药物细胞孔开始出现病变 ,48h后细胞全部病变、死亡 ,表明合成的 13种小的药物均不能有效地抑制SARS病毒的繁殖。 Objective To explore the drug against SARS coronavirus and study the anti-SARS virus activities of 13 different synthetic small molecular drugs on the cell culture system. Methods Anti-SARS virus activities of drugs were determined based on the data obtained by using micropore plastic plate and MTT thchnique. Results Within 2 hours after inoculating SARS virus,the drugs of No.3?4?7 and 8 had anti-SARS effect.The drug of No.9 had significant effect within 30 hours.SARS virus proliferated quickly 36 hours after inoculation. CPE ocurred to all cells 48 hours after inoculating SARS virus.Results of the two methods were coincident. Conclusion There are 5 of the 13 drugs have anti-SARS effect to some extent within 20 hours after inoculating SARS virus, and CPE ocurred to all cells 30 hours after in oculation. After 48 hours,and cells died.It showed that all the 13 drugs could not inhibit SARS Coronavims effectinely.
出处 《中国热带医学》 CAS 2004年第5期695-696,共2页 China Tropical Medicine
关键词 SARS病毒 小分子药物 SARS冠状病毒 MTT法 体外实验研究 抑制 细胞病变 接种 繁殖 药效 Severe Acute Respiratory Syndrome(SARS) Screen of drugs Cell pathological changes(CPE)
  • 相关文献

参考文献4

  • 1[1]Lavi E, Weiss SR, Hi ngley ST.The nidovirusese (coronaviruess and arterviruses)[J].Dordrechd, Netherland: Kluwer Academic/Plenum publication,2001.1 ~ 72.
  • 2[2]Anand K,Ziebuhr J,Wadhwani P, et al. Coronavirus main proteinase(3CL pro)structure: Basis for design of anti - SARS drugs[J] .Science.2003, 13; 300(5626): 1763 ~ 1767.
  • 3[3]Xu X,Liu Y,Weiss S,et al. Molecular model of SARS coronavirus polymerase:implications for biochemiscal functions and drug design [J] .Nucleic Acids Res.2003,15;31 (24) ;7117 ~ 7130.
  • 4陈志南,徐静.SARS冠状病毒的研究现状[J].第四军医大学学报,2003,24(11):1055-1056. 被引量:6

二级参考文献1

  • 1QIN E'de,ZHU Qingyu,YU Man, FAN Baochang,CHANG Guohui,SI Bingyin,YANG Bao,PENG Wenming,JIANG Tao,LIU Bohua,DENG Yongqiang,LIU Hong,ZHANG Yu,WANG Cui,LI Yuquan,GAN Yonghua,LI Xiaoyu,L Fushuang,TAN Gang,CAO Wuchun,YANG Ruifu,WANG Jian,LI Wei,XU Zuyuan,LI Yan,WU Qingfa,LIN Wei,CHEN Weijun,TANG Lin,DENG Yajun,HAN Yujun,LI Changfeng,LEI Meng,LI Guoqing,LI Wenjie,L Hong,SHI Jianping,TONG Zongzhong,ZHANG Feng,LI Songgang,LIU Bin,LIU Siqi,DONG Wei,WANG Jun,Gane K-S Wong,YU Jun,YANG Huanming.A complete sequence and comparative analysis of a SARS-associated virus(Isolate BJ01)[J].Chinese Science Bulletin,2003,48(10):941-948. 被引量:123

共引文献5

同被引文献13

引证文献1

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部